Navigation Links
KaloBios Appoints Donald R. Joseph as Chief Legal Officer
Date:6/17/2013

ved U.S. FDA Fast Track Designation.
  • KB004, an anti-EphA3 mAb, has potential in treating hematologic malignancies and solid tumors. KaloBios is currently testing this drug in a Phase 1 study in subjects with hematologic malignancies.
  • All of the company's antibodies were generated using its proprietary Humaneered® technology, a method that converts nonhuman antibodies (typically mouse) into recombinant antibodies that have a high binding affinity to their target and are designed for chronic therapeutic use. The company believes that antibodies produced using its Humaneered® technology offer important clinical and economic advantages over antibodies generated by other methods in terms of high binding affinity, high manufacturing yields, and minimal to no immunogenicity (inappropriate immune response) upon repeat administration in humans.

    For more information on KaloBios Pharmaceuticals, please visit our web site at http://www.kalobios.com.

    Forward Looking Statements
    This release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including:  the statements under the heading "Anticipated Upcoming Milestones for 2013-2014"; and statements regarding the company's clinical development of KB001-A, KB003 and KB004. Forward-looking statements reflect management's current knowledge, assumptions, judgment and expectations regarding future performance or events. Although management believes that the expectations reflected in such statements are reasonable, they give no assurance that such expectations will prove to be correct and you should be aware that actual results could differ materially from those contained in the forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties including, but not limited to, the company's
    '/>"/>

    SOURCE KaloBios Pharmaceuticals
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related biology technology :

    1. U.S. FDA Grants Fast-Track Designation to Sanofi Pasteur and KaloBios Novel Biologic Candidate for Pseudomonas aeruginosa
    2. KaloBios Announces Fiscal Year 2012 Financial Results
    3. Organovo Appoints Tamar D. Howson to Board of Directors
    4. Microvi Biotechnologies Appoints Former COO of Zenon Environmental as Chairman of Board of Directors
    5. PTC Therapeutics Appoints Shane Kovacs as Chief Financial Officer
    6. SPIE Appoints Ni-Bin Chang Editor of Journal of Applied Remote Sensing
    7. Envera Appoints Michael McErlean Fermentation Manager
    8. WMIS Appoints Lisa Baird as Next Executive Director
    9. Intra-Cellular Therapies Appoints Professor Sir Michael Rawlins to its Board of Directors
    10. Alacrita Aggregates the Life Science Practices of Two Consulting Firms and Appoints Simon Turner Ph.D FRSC as Partner
    11. Ohr Pharmaceutical Appoints Thomas M. Riedhammer To Board Of Directors
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/30/2014)... 2014 Whitehouse Laboratories has formally announced ... Testing and Package Test Capacity. Responding to growing demands ... dramatic increase in environmental chamber storage space that will ... aging samples to be securely held on site at ... expenditure has already taken place with the recent completion ...
    (Date:10/30/2014)... Calif. , Oct. 30, 2014 Isis Pharmaceuticals, ... therapeutics, today announced that management will present a company overview ... at 8:30 a.m. ET in Boston, MA. ... be available on the "Investors & Media" section of the ... on the Isis website within 48 hours and will be ...
    (Date:10/30/2014)... challenges in the development of quantum technologies has been ... paper published today (28 October) in Nature Communications ... make a new type of flexibly designed microscopic trap ... sensors and specialised superfast computers, often depend on harnessing ... trapping these tiny particles are hugely problematic because of ...
    (Date:10/27/2014)... The new research report, “Gas Insulated Switchgear (GIS) ... & Secondary), and End-User (Transmission & Distribution, Manufacturing ... - Trends and Forecasts to 2019”, defines and ... of the market size. , Browse more than ... through 146 Pages and in-depth TOC on “Gas ...
    Breaking Biology Technology:Whitehouse Labs Announces Major Capital Investment in Stability and Storage Testing Capacity 2Whitehouse Labs Announces Major Capital Investment in Stability and Storage Testing Capacity 3Isis Pharmaceuticals to Present at the Nomura Biotechnology Conference 2Gas Insulated Switchgear Market worth $21,951.9 Million by 2019 - New Report by MarketsandMarkets 2Gas Insulated Switchgear Market worth $21,951.9 Million by 2019 - New Report by MarketsandMarkets 3Gas Insulated Switchgear Market worth $21,951.9 Million by 2019 - New Report by MarketsandMarkets 4
    ... Oct. 10 /Xinhua-PRNewswire-FirstCall/ -- Pharmaxis,(ASX: PXS; Nasdaq: PXSL) ... a placement to Australian, U.S., Asian and European ... balance,sheet as Pharmaxis continues with a series of ... of its manufacturing operation in,Sydney. Pharmaxis will ...
    ... October 10 The National,Institutes of Allergy and ... with Bavarian Nordic to include the initiation of,a ... investigational,smallpox vaccine, in persons diagnosed with atopic dermatitis. ... 2010 and has a value of,US$15 million, with ...
    ... OPK ),today announced that it has acquired exclusive ... compound with potential utility,in the treatment of dry eye. ... can disrupt the lives,of those afflicted. It can cause ... Sam Reich, Executive Vice President,of Ophthalmologics at OPKO. "There ...
    Cached Biology Technology:Pharmaxis Announces Placement of $50 Million and Share Purchase Plan 2Government Expands Trial With IMVAMUNE(R) Smallpox Vaccine in Persons With Atopic Dermatitis/Eczema 2Government Expands Trial With IMVAMUNE(R) Smallpox Vaccine in Persons With Atopic Dermatitis/Eczema 3OPKO Health Acquires Rights to Clinical Stage Compound for Dry Eye 2OPKO Health Acquires Rights to Clinical Stage Compound for Dry Eye 3
    (Date:10/30/2014)... 30 October 2014 Biological membranes are mainly composed ... adsorption of solution ions onto lipid membranes helps ... new study provides a quantitative description of the ... Joanna Kotyńska and Zbigniew Figaszewski from the University ... study describing these findings, just published in ...
    (Date:10/29/2014)... OR) New research presented at the Society ... Houston, TX showed for the first time that ... women using a readily available nutritional supplement, AHCC. ... Dr. Judith A. Smith, Pharm.D., associate professor in ... at The University of Texas Health Science Center ...
    (Date:10/29/2014)... the safety of nanoparticles is all the rage. Thousands ... examining the question of whether titanium dioxide nanoparticles from ... the body, whether carbon nanotubes from electronic products are ... be or whether nanoparticles in food can get into ... interest is great, research funds are flowing – and ...
    Breaking Biology News(10 mins):Ion adsorption matter in biology 2HPV infections in women eradicated by AHCC, Japanese mushroom extract 2Nanosafety research: The quest for the gold standard 2Nanosafety research: The quest for the gold standard 3
    ... Scientists and engineers must join together in a major new ... crisis in providing Earth,s people with clean water that looms ... comment article in the current edition of Chemical & ... Society (ACS), the world,s largest scientific society. Bassam Z. ...
    ... of potential environmental and human health effects from disposal ... led scientists to recommend stronger government policies to encourage ... That,s the conclusion of a new paper in the ... Oladele A. Ogunseitan and colleagues point out that Li-ion ...
    ... life scientists provide important new details on how climate change ... 21 in the Journal of Animal Ecology . This ... informing policymakers of how species are likely to be impacted ... recognition among biologists that climate change is affecting how species ...
    Cached Biology News:UCLA life scientists present new insights on climate change and species interactions 2UCLA life scientists present new insights on climate change and species interactions 3UCLA life scientists present new insights on climate change and species interactions 4UCLA life scientists present new insights on climate change and species interactions 5
    ... BioNumerics is the universal bioinformatics software that ... data. The unique modular design of BioNumerics ... virtually any type of data employed for ... microarrays, DNA fingerprints, 2-D protein gels, HPLC, ...
    ... early 80s Biosearch Technologies has been ... tools to accelerate the discovery and ... need dual-labeled FRET probes and primers ... for microarray applications, Biosearch can meet ...
    UNIVERSAL SCORECARD DNA, 1 EA. * Category: Reagents/Consumables....
    mitochondrial proteins (human heart) for 2-D gel electrophoresis *5 mg/mL*...
    Biology Products: